Anti-GBRA1/ GABRA1/ ECA4 monoclonal antibody

Anti-GBRA1/ GABRA1/ ECA4 antibody for FACS & in-vivo assay

Target products collectionGo to GABRA1/GABRA1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T51487-Ab-1/ GM-Tg-hg-T51487-Ab-2Anti-Human GABRA1 monoclonal antibodyHuman
GM-Tg-rg-T51487-Ab-1/ GM-Tg-rg-T51487-Ab-2Anti-Rat GABRA1 monoclonal antibodyRat
GM-Tg-mg-T51487-Ab-1/ GM-Tg-mg-T51487-Ab-2Anti-Mouse GABRA1 monoclonal antibodyMouse
GM-Tg-cynog-T51487-Ab-1/ GM-Tg-cynog-T51487-Ab-2Anti-Cynomolgus/ Rhesus macaque GABRA1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T51487-Ab-1/ GM-Tg-felg-T51487-Ab-2Anti-Feline GABRA1 monoclonal antibodyFeline
GM-Tg-cang-T51487-Ab-1/ GM-Tg-cang-T51487-Ab-2Anti-Canine GABRA1 monoclonal antibodyCanine
GM-Tg-bovg-T51487-Ab-1/ GM-Tg-bovg-T51487-Ab-2Anti-Bovine GABRA1 monoclonal antibodyBovine
GM-Tg-equg-T51487-Ab-1/ GM-Tg-equg-T51487-Ab-2Anti-Equine GABRA1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T51487-Ab-1/ GM-Tg-hg-T51487-Ab-2; GM-Tg-rg-T51487-Ab-1/ GM-Tg-rg-T51487-Ab-2;
GM-Tg-mg-T51487-Ab-1/ GM-Tg-mg-T51487-Ab-2; GM-Tg-cynog-T51487-Ab-1/ GM-Tg-cynog-T51487-Ab-2;
GM-Tg-felg-T51487-Ab-1/ GM-Tg-felg-T51487-Ab-2; GM-Tg-cang-T51487-Ab-1/ GM-Tg-cang-T51487-Ab-2;
GM-Tg-bovg-T51487-Ab-1/ GM-Tg-bovg-T51487-Ab-2; GM-Tg-equg-T51487-Ab-1/ GM-Tg-equg-T51487-Ab-2
Products NameAnti-GABRA1 monoclonal antibody
Formatmab
Target NameGABRA1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GABRA1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species GBRA1/ GABRA1/ ECA4 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP001509human GABRA1 Lentivirus particle
    ORF Viral VectorpGMLP001509human GABRA1 Lentivirus plasmid
    ORF Viral VectorpGMLPm002946mouse Gabra1 Lentivirus plasmid
    ORF Viral VectorvGMLPm002946mouse Gabra1 Lentivirus particle


    Target information

    Target IDGM-T51487
    Target NameGABRA1
    Gene ID2554,14394,29705,574302,489143,100286792,780973,100070870
    Gene Symbol and SynonymsDEE19,ECA4,EIEE19,EJM,EJM5,GABAA-alpha1,GABAAR-alpha1,Gabra-1,GABRA1
    Uniprot AccessionP14867,P62813,P08219
    Uniprot Entry NameGBRA1_HUMAN,GBRA1_RAT,GBRA1_BOVIN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000022355
    Target ClassificationIon Channel

    The target: GABRA1, gene name: GABRA1, also named as ECA4, EIEE19, EJM, EJM5. This gene encodes a gamma-aminobutyric acid (GABA) receptor. GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. GABA-A receptors are pentameric, consisting of proteins from several subunit classes: alpha, beta, gamma, delta and rho. Mutations in this gene cause juvenile myoclonic epilepsy and childhood absence epilepsy type 4. Multiple transcript variants encoding the same protein have been identified for this gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.